Lakefront Biotherapeutics NV
ISIN BE0003818359
Lakefront Biotherapeutics NV has no current public net short positions above the disclosure threshold. The last disclosure was by Arrowstreet Capital Limited Partnership of 0.48% on 2026-04-02, reported to AFM.
Total net short positions over time
Previous position holders
No current positions above the disclosure threshold. Most recent disclosures per holder:
- Arrowstreet Capital Limited Partnership0.48%2026-04-02
- Qube Research & Technologies Ltd0.49%2025-12-22
- Millennium International Management LP0.29%2025-08-26
- Citadel Advisors LLC0.48%2025-07-17
- Marshall Wace LLP0.49%2025-04-14
- Connor Clark & Lunn Investment Management Ltd0.49%2025-02-21
- WorldQuant LLC0.48%2025-02-05
- AHL Partners LLP0.49%2023-07-05
- AQR Capital Management LLC0.49%2022-11-28
- Canada Pension Plan Investment Board0.44%2022-01-27
Data is sourced from Autoriteit Financiële Markten, which publishes net short position disclosures on its public, free-to-access website. ShortsInsights.com republishes this information for convenience and may apply formatting, grouping, and cleaning that can introduce differences from the source. Data may be delayed, incomplete, or inaccurate, and may not reflect the most recent filings or corrections.
ShortsInsights.com is provided "as is" for informational purposes only and does not constitute investment, legal, or other advice. Users should verify any information directly with Autoriteit Financiële Markten before making decisions. ShortsInsights.com and its operators disclaim liability for errors, omissions, or actions taken in reliance on the information to the fullest extent permitted by law.